Annovis Bio, Inc. Basic Shares Outstanding (Weighted Average)
Annovis Bio, Inc. (ANVS) reported Basic Shares Outstanding (Weighted Average) of 37.52 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Annovis Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 37.52M shares, a 92.54% increase year-over-year.
- Annovis Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 27.85M shares, a 59.76% increase year-over-year.
- Annovis Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 25.58M shares, a 75.86% increase year-over-year.
- Annovis Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 19.69M shares, a 51.71% increase year-over-year.
- Annovis Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 20.55M shares, a 68.70% increase from fiscal 2024.
- Annovis Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 12.18M shares, a 35.01% increase from fiscal 2023.
- Annovis Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 9.02M shares, a 10.55% increase from fiscal 2022.
- Annovis Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 8.16M shares, a 7.03% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 37.52M shares 10-Q · filed 2026-08-14 | 32.71M shares 10-Q · filed 2026-08-14 | 30.32M shares derived: average of 3 quarters · filed 2026-08-14 | 27.66M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 27.85M shares 10-Q · filed 2026-05-15 | 26.71M shares derived: average of 2 quarters · filed 2026-05-15 | 24.37M shares derived: average of 3 quarters · filed 2026-05-15 | 23.15M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | 25.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 22.63M shares derived: average of 2 quarters · filed 2026-03-13 | 21.58M shares derived: average of 3 quarters · filed 2026-08-14 | 20.55M shares 10-K · filed 2026-03-13 |
| 2025-09-30 | 19.69M shares 10-Q · filed 2025-11-12 | 19.59M shares derived: average of 2 quarters · filed 2026-08-14 | 18.88M shares 10-Q · filed 2025-11-12 | 17.79M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | 19.49M shares 10-Q · filed 2026-08-14 | 18.46M shares 10-Q · filed 2026-08-14 | 17.15M shares derived: average of 3 quarters · filed 2026-08-14 | 16.11M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 17.43M shares 10-Q · filed 2026-05-15 | 15.99M shares derived: average of 2 quarters · filed 2026-05-15 | 14.98M shares derived: average of 3 quarters · filed 2026-05-15 | 14.07M shares derived: average of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | 14.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 13.76M shares derived: average of 2 quarters · filed 2026-03-13 | 12.94M shares derived: average of 3 quarters · filed 2026-03-13 | 12.18M shares 10-K · filed 2026-03-13 |
| 2024-09-30 | 12.98M shares 10-Q · filed 2025-11-12 | 12.14M shares derived: average of 2 quarters · filed 2025-11-12 | 11.39M shares 10-Q · filed 2025-11-12 | 11.21M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 11.31M shares 10-Q · filed 2025-08-12 | 10.97M shares 10-Q · filed 2025-08-12 | 10.62M shares derived: average of 3 quarters · filed 2025-08-12 | 10.22M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 10.63M shares 10-Q · filed 2025-05-13 | 10.28M shares derived: average of 2 quarters · filed 2025-05-13 | 9.85M shares derived: average of 3 quarters · filed 2025-05-13 | 9.63M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 9.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 9.47M shares derived: average of 2 quarters · filed 2025-03-21 | 9.30M shares derived: average of 3 quarters · filed 2025-03-21 | 9.02M shares 10-K · filed 2025-03-21 |
| 2023-09-30 | 9.01M shares 10-Q · filed 2024-11-08 | 8.98M shares derived: average of 2 quarters · filed 2024-11-08 | 8.72M shares 10-Q · filed 2024-11-08 | 8.58M shares derived: average of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | 8.95M shares 10-Q · filed 2024-08-14 | 8.58M shares 10-Q · filed 2024-08-14 | 8.44M shares derived: average of 3 quarters · filed 2024-08-14 | 8.37M shares derived: average of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | 8.19M shares 10-Q · filed 2024-05-10 | 8.18M shares derived: average of 2 quarters · filed 2024-05-10 | 8.17M shares derived: average of 3 quarters · filed 2024-05-10 | 8.17M shares derived: average of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | 8.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 8.16M shares derived: average of 2 quarters · filed 2024-03-29 | 8.16M shares derived: average of 3 quarters · filed 2024-03-29 | 8.16M shares 10-K · filed 2024-03-29 |
| 2022-09-30 | 8.16M shares 10-Q · filed 2023-11-08 | 8.16M shares derived: average of 2 quarters · filed 2023-11-08 | 8.16M shares 10-Q · filed 2023-11-08 | 8.15M shares derived: average of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | 8.16M shares 10-Q · filed 2023-08-14 | 8.16M shares 10-Q · filed 2023-08-14 | 8.14M shares derived: average of 3 quarters · filed 2023-08-14 | 8.13M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | 8.16M shares 10-Q · filed 2023-05-10 | 8.13M shares derived: average of 2 quarters · filed 2023-05-10 | 8.12M shares derived: average of 3 quarters · filed 2023-05-10 | 7.93M shares derived: average of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | 8.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 8.10M shares derived: average of 2 quarters · filed 2023-03-31 | 7.86M shares derived: average of 3 quarters · filed 2023-03-31 | 7.63M shares 10-K · filed 2023-03-31 |
| 2021-09-30 | 8.10M shares 10-Q · filed 2022-11-08 | 7.73M shares derived: average of 2 quarters · filed 2022-11-08 | 7.47M shares 10-Q · filed 2022-11-08 | 7.32M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 7.37M shares 10-Q · filed 2022-08-08 | 7.14M shares 10-Q · filed 2022-08-08 | 7.06M shares derived: average of 3 quarters · filed 2022-08-08 | 7.01M shares derived: average of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | 6.92M shares 10-Q · filed 2022-05-04 | 6.91M shares derived: average of 2 quarters · filed 2022-05-04 | 6.90M shares derived: average of 3 quarters · filed 2022-05-04 | |
| 2020-12-31 | 6.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | 6.88M shares derived: average of 2 quarters · filed 2022-03-02 | 6.31M shares 10-K · filed 2022-03-02 | |
| 2020-09-30 | 6.87M shares 10-Q · filed 2021-11-03 | 6.11M shares 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |